StockGuru Spotlight on Abattis
(Symbol: ATTBF)
Help us update information on this company. Email any updates to: [email protected]
Abattis:
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions by supplying and partnering with companies to employ its vertical cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The company also has an extensive pipeline of high-quality products and Intellectual Property for the rapidly expanding botanical drug market. We follow strict Standard Operating Protocols and adhere to the Law’s of Canada and Foreign Jurisdictions..
Their Companies:
Biocube Green Grow Systems Corp. is a wholly owned subsidiary of Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT) that provides controlled cannabis cultivation environments for high yield marijuana growing. The company has exclusive worldwide rights to a building product derived from magnesium oxide known as MgO board, which has applications in all areas of the building and construction industry as a fireproof, antimicrobial, antibacterial, waterproof, and recyclable material.
iJuana Inc. is a wholly owned subsidiary of Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT) that has has leased a 27,000 sq. ft. facility in a pre-appoved zoned area to become a Licensed Producer under Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). With operations in Squamish, British Columbia, the company aims to become the licensed cannabis growing arm and consumer-facing entity for Abattis Bioceuticals. The market for medicinal marijuana is estimated to reach $1.3 billion in Canada by 2024, according to estimates made by Health Canada. iJuana owns 75 Natural Health Product Licenses “NPN’s” issued by Health Canada.
.
Biocell Labs Inc. is a wholly owned subsidiary of Abattis Bioceutical Corp. (OTC: ATTBF) (CSE: ATT) focused on supplying standardized pharmaceutical grade products. The company leases a $13M, 20k square foot a botanical drug facility that it will use to perform quality testing and refining using its proprietary Flash Freeze Extraction (“FFE”) and water extraction technologies. Currently, the company has 13 proprietary formulations for out-licensing to cosmetic, nutraceutical and pharmaceutical companies.
North American Bioextracts Inc. is the wholly owned retail distribution arm of Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT) operating in Canada and Washington State that will focus on cannabis, cannabis derivatives, and ancillary products like vaporizers where legally permitted. The company aims to use its proprietary extraction technologies to develop customized THC extract oils and CBD extract oils, as well as customized vaporizer flavors to enhance the end user’s experience.
Northern Vine Canada has applied for a Controlled Substance License with Health Canada, with an existing cannabis processing, testing, and packaging facility located in Langley, British Columbia. In addition to these services, the company will support its operations by providing analytical services for Licensed Producers and charging a fee to produce a Certificate of Analysis. The firm will also formulate compositions for sprays, creams, and tinctures that it plans to patent.
Where it is located:
405 Lexington Avenue
355 Burrard Street
New York, BC
10174
USA
Key Executive Contact:
Rene David
CFO, COO
Ninety Day Volume:
452768 (as of date of publication)
Ninety Day Dollar Volume:
$216,876
Share Information:
47619090 shares as of 2014-03-12
Corporate Information:
State Incorporated: BC
Country Incorporated: CAN
Contact, Website and Social Media for Abattis
Shown Where Available
Website: www.abattis.com
Facebook:
Twitter:
LinkedIn:
Telephone: (212) 704-6193
Email: [email protected]
Investor Relations for Abattis:
TDM Financial